protenus extends series a funding round to accommodate strategic support from kaiser permanente ventures and fprime capital partners  newswire protenus extends series a funding round to accommodate strategic support from kaiser permanente ventures and fprime capital partners additional investment brings series a to m and funds accelerated growth building on existing success amid growing market demand press release  updated jul   baltimore md july   newswirecom  ​protenus the healthcare industry’s most robust analyticsdriven solution for protecting patient privacy and preventing health data breaches today announced a m extension of its series a funding round led by kaiser permanente ventures with participation from fprime capital partners and existing investor lionbird venture partners the new investment will be used to bolster its industryleading product expand product offerings and accelerate sales growth as most hospitals have transitioned to electronic health records patient data has never been more vulnerable in  over  million patient records were breached as noted by the protenus breach barometer so far  has averaged more than one health data breach per day with over  of these incidents attributable to insiders protenus uses advanced analytics to identify anomalous behaviors within a hospital’s electronic health records and associated systems by leveraging an array of artificial intelligence techniques to build a comprehensive understanding of clinical and administrative workflows protenus detects when individuals inappropriately access patient data ensuring trust throughout health data systems since its founding in  protenus has worked with premier healthcare systems and hospitals across the country protecting the privacy of more than  million patients we founded protenus with the mission of empowering hospitals to protect the privacy of their patients weve built a solution that is a paradigm shift from how hospitals have typically met patient privacy monitoring needs using predictive analytics and big data frameworks with this more modern approach weve been able to tap into immense market growth while protecting the critical and trusted relationships hospitals have with their patients nick culbertson cofounder and ceo we founded protenus with the mission of empowering hospitals to protect the privacy of their patients we’ve built a solution that is a paradigm shift from how hospitals have typically met patient privacy monitoring needs using predictive analytics and big data frameworks with this more modern approach weve been able to tap into immense market growth while protecting the critical and trusted relationships hospitals have with their patients said nick culbertson protenus cofounder and ceo the company raised a m series a round in february  and with this extension sought to bring in strategic and financial partners with expertise in healthcare and cybersecurity to propel its growth in the market an investment from kaiser permanente ventures and fprime capital partners will support the company as we advance our efforts to bring this innovative nextgeneration solution to the patient privacy monitoring market said protenus cofounder and president robert lord this support from two of the industry’s top institutional investors brings additional industry expertise to our team and helps us meet the increasing demand for the protenus platform about protenus protenus protects patient privacy in the electronic health record ehr for topranked hospitals using the latest big data techniques and protenusled advances in data science machine learning visualization and software engineering the protenus platform uniquely understands the clinical behavior and context of each person accessing patient data to determine the appropriateness of each action elevating only true threats to patient privacy protenus and its partner hospitals are fundamentally improving the way hospitals protect their patient data — further ensuring trust in healthcare learn more at protenuscom and follow us on twitter protenus about kaiser permanente ventures kaiser permanente ventures is the strategic venture capital arm of kaiser permanente the largest integrated healthcare system in the united states serving more than  million people nationwide kaiser permanente ventures invests exclusively in companies that advance the quality accessibility and affordability of healthcare about fprime capital partners fprime capital partners is a global venture capital firm investing in life sciences healthcare and technology since  fprime has worked closely with entrepreneurs and academics to create innovative solutions to some of the worlds most significant challenges in healthcare and technology for more information please visit wwwfprimecapitalcom press contact kira caban​director public relations​kiraprotenuscom source protenus share on facebook share on twitter categories investments healthcare healthcare technology artificial intelligence and expert systems healthcare and medical news tags artificial intelligence data analytics health data breaches healthcare investment patient data patient privacy series a about protenus inc view website protenus protects patient data in the ehr for some of the nations topranked hospitals we uniquely understand the clinical behavior and context of each user access and determine its appropriateness elevating only true threats to patient privacy contact information kira caban protenus inc mocsunetorparik  company address protenus inc  bank street rd floor baltimore md  united states more press releases leading healthcare institutions assemble to shape innovation in patient privacy analytics protenus hosts inaugural privacy and analytics pandas conference to foster best practices for privacy officers using data analytics and ai protenus inc  mar   protenus robert lord selected as speaker for himss protenus inc  jan   nations leading cybersecurity think tank selects protenus for healthcare analytics expertise protenus cofounders selected as icit fellows in response to continuing onslaught of health data breaches protenus inc  oct   newswire get notified about new releases sign up for email updates from newswire enter your email address notification frequency press releases instant daily never news instant daily never event instant daily never blog daily never facebook daily never twitter daily never subscribe protenus extends series a funding round to accommodate strategic support from kaiser permanente ventures and fprime capital partners  newswire protenus extends series a funding round to accommodate strategic support from kaiser permanente ventures and fprime capital partners additional investment brings series a to m and funds accelerated growth building on existing success amid growing market demand press release  updated jul   baltimore md july   newswirecom  ​protenus the healthcare industry’s most robust analyticsdriven solution for protecting patient privacy and preventing health data breaches today announced a m extension of its series a funding round led by kaiser permanente ventures with participation from fprime capital partners and existing investor lionbird venture partners the new investment will be used to bolster its industryleading product expand product offerings and accelerate sales growth as most hospitals have transitioned to electronic health records patient data has never been more vulnerable in  over  million patient records were breached as noted by the protenus breach barometer so far  has averaged more than one health data breach per day with over  of these incidents attributable to insiders protenus uses advanced analytics to identify anomalous behaviors within a hospital’s electronic health records and associated systems by leveraging an array of artificial intelligence techniques to build a comprehensive understanding of clinical and administrative workflows protenus detects when individuals inappropriately access patient data ensuring trust throughout health data systems since its founding in  protenus has worked with premier healthcare systems and hospitals across the country protecting the privacy of more than  million patients we founded protenus with the mission of empowering hospitals to protect the privacy of their patients weve built a solution that is a paradigm shift from how hospitals have typically met patient privacy monitoring needs using predictive analytics and big data frameworks with this more modern approach weve been able to tap into immense market growth while protecting the critical and trusted relationships hospitals have with their patients nick culbertson cofounder and ceo we founded protenus with the mission of empowering hospitals to protect the privacy of their patients we’ve built a solution that is a paradigm shift from how hospitals have typically met patient privacy monitoring needs using predictive analytics and big data frameworks with this more modern approach weve been able to tap into immense market growth while protecting the critical and trusted relationships hospitals have with their patients said nick culbertson protenus cofounder and ceo the company raised a m series a round in february  and with this extension sought to bring in strategic and financial partners with expertise in healthcare and cybersecurity to propel its growth in the market an investment from kaiser permanente ventures and fprime capital partners will support the company as we advance our efforts to bring this innovative nextgeneration solution to the patient privacy monitoring market said protenus cofounder and president robert lord this support from two of the industry’s top institutional investors brings additional industry expertise to our team and helps us meet the increasing demand for the protenus platform about protenus protenus protects patient privacy in the electronic health record ehr for topranked hospitals using the latest big data techniques and protenusled advances in data science machine learning visualization and software engineering the protenus platform uniquely understands the clinical behavior and context of each person accessing patient data to determine the appropriateness of each action elevating only true threats to patient privacy protenus and its partner hospitals are fundamentally improving the way hospitals protect their patient data — further ensuring trust in healthcare learn more at protenuscom and follow us on twitter protenus about kaiser permanente ventures kaiser permanente ventures is the strategic venture capital arm of kaiser permanente the largest integrated healthcare system in the united states serving more than  million people nationwide kaiser permanente ventures invests exclusively in companies that advance the quality accessibility and affordability of healthcare about fprime capital partners fprime capital partners is a global venture capital firm investing in life sciences healthcare and technology since  fprime has worked closely with entrepreneurs and academics to create innovative solutions to some of the worlds most significant challenges in healthcare and technology for more information please visit wwwfprimecapitalcom press contact kira caban​director public relations​kiraprotenuscom source protenus share on facebook share on twitter categories investments healthcare healthcare technology artificial intelligence and expert systems healthcare and medical news tags artificial intelligence data analytics health data breaches healthcare investment patient data patient privacy series a about protenus inc view website protenus protects patient data in the ehr for some of the nations topranked hospitals we uniquely understand the clinical behavior and context of each user access and determine its appropriateness elevating only true threats to patient privacy contact information kira caban protenus inc mocsunetorparik  company address protenus inc  bank street rd floor baltimore md  united states more press releases leading healthcare institutions assemble to shape innovation in patient privacy analytics protenus hosts inaugural privacy and analytics pandas conference to foster best practices for privacy officers using data analytics and ai protenus inc  mar   protenus robert lord selected as speaker for himss protenus inc  jan   nations leading cybersecurity think tank selects protenus for healthcare analytics expertise protenus cofounders selected as icit fellows in response to continuing onslaught of health data breaches protenus inc  oct   newswire get notified about new releases sign up for email updates from newswire enter your email address notification frequency press releases instant daily never news instant daily never event instant daily never blog daily never facebook daily never twitter daily never subscribe kaiser permanente ventures llc series a sc d filing concerning irtc on  whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active schedule d filed by kaiser permanente ventures llc series a total shares  subject company irhythm technologies inc  view complete ownership history backtest filed as of date  event date  overall  ownership  reporting persons name solevoting power sharedvoting power soledispositive power shareddispositive power aggregateamount owned percentof class kaiser permanente ventures llc – series       kaiser permanente ventures llc – series       the permanente federation llc – series i       the permanente federation llc – series j       view original filing on edgars raw filing contents txt   hdrsgml    accession number  conformed submission type sc d public document count  filed as of date  date as of change  group members kaiser permanente ventures llc series b group members permanente federation llc series i group members permanente federation llc series j subject company company data company conformed name irhythm technologies inc central index key  standard industrial classification surgical  medical instruments  apparatus  irs number  state of incorporation de fiscal year end  filing values form type sc d sec act  act sec file number  film number  business address street   townsend street street  suite  city san francisco state ca zip  business phone  mail address street   townsend street street  suite  city san francisco state ca zip  former company former conformed name irhythm technologies inc date of name change  former company former conformed name irhythm technologies inc date of name change  filed by company data company conformed name kaiser permanente ventures llc series a central index key  irs number  state of incorporation de fiscal year end  filing values form type sc d business address street  one kaiser plaza suite  city oakland state ca zip  business phone   mail address street  one kaiser plaza suite  city oakland state ca zip  sc d  ddscdhtm sc d sc d     united states securities and exchange commission washington dc      schedule d under the securities exchange act of  amendment no          irhythm technologies inc name of issuer common stock title of class of securities   cusip number marcus j williams davis wright tremaine llp  third avenue suite  seattle wa    name address and telephone number of person authorized to receive notices and communications october   date of event which requires filing of this statement     if the filing person has previously filed a statement on schedule g to report the acquisition that is the subject of this schedule d and is filing this schedule because of §§ de df or dg check the following box  ☒     note schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits see § d for other parties to whom copies are to be sent        the remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page the information required on the remainder of this cover page shall not be deemed to be filed for the purpose of section  of the securities exchange act of  act or otherwise subject to the liabilities of that section of act but shall be subject to all other provisions of the act however see the notes       cusip no            names of reporting persons   kaiser permanente ventures llc  series a      check the appropriate box if a member of a group see instructions a  ☐        b  ☒        sec use only        source of funds see instructions   pf      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states number of shares beneficially owned by each reporting person with             sole voting power             shared voting power             sole dispositive power           shared dispositive power       aggregate amount beneficially owned by each reporting person        check box if the aggregate amount in row  excludes certain shares see instructions      percent of class represented by amount in row         type of reporting person see instructions   oo    includes  shares of common stock currently held by the filing person identified herein and  shares of common stock issuable upon the exercise of warrants held by such filing person and exercisable within  days of this report  includes shares attributable to the filing person by virtue of its deemed membership in a group as that term is defined for purposes of section d of the securities exchange act the filing person does not admit that it is acting in concert with the other filing persons with respect to the voting or disposition of the securities described herein and attributable to the filing person by virtue of its inclusion in a group pursuant to rule da other than as descried under item c below  based on  shares of the issuers common stock outstanding upon the completion of the registrants initial public offering based upon the registrants prospectus supplement filed with the commission under rule b on october   cusip no            names of reporting persons   kaiser permanente ventures llc  series b      check the appropriate box if a member of a group see instructions a  ☐        b  ☒        sec use only        source of funds see instructions   pf      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states number of shares beneficially owned by each reporting person with             sole voting power             shared voting power             sole dispositive power           shared dispositive power       aggregate amount beneficially owned by each reporting person        check box if the aggregate amount in row  excludes certain shares see instructions      percent of class represented by amount in row         type of reporting person see instructions   oo    includes  shares of common stock currently held by the filing person identified herein and  shares of common stock issuable upon the exercise of warrants held by such filing person and exercisable within  days of this report  includes shares attributable to the filing person by virtue of its deemed membership in a group as that term is defined for purposes of section d of the securities exchange act the filing person does not admit that it is acting in concert with the other filing persons with respect to the voting or disposition of the securities described herein and attributable to the filing person by virtue of its inclusion in a group pursuant to rule da other than as descried under item c below  based on  shares of the issuers common stock outstanding upon the completion of the registrants initial public offering based upon the registrants prospectus supplement filed with the commission under rule b on october   cusip no            names of reporting persons   the permanente federation llc  series i      check the appropriate box if a member of a group see instructions a  ☐        b  ☒        sec use only        source of funds see instructions   pf      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states number of shares beneficially owned by each reporting person with             sole voting power             shared voting power             sole dispositive power           shared dispositive power       aggregate amount beneficially owned by each reporting person        check box if the aggregate amount in row  excludes certain shares see instructions      percent of class represented by amount in row         type of reporting person see instructions   oo    includes shares attributable to the filing person by virtue of its deemed membership in a group as that term is defined for purposes of section d of the securities exchange act the filing person does not admit that it is acting in concert with the other filing persons with respect to the voting or disposition of the securities described herein and attributable to the filing person by virtue of its inclusion in a group pursuant to rule da except as described under item c below  based on  shares of the issuers common stock outstanding upon the completion of the registrants initial public offering based upon the registrants prospectus supplement filed with the commission under rule b on october   cusip no            names of reporting persons   the permanente federation llc  series j      check the appropriate box if a member of a group see instructions a  ☐        b  ☒        sec use only        source of funds see instructions   pf      check if disclosure of legal proceedings is required pursuant to items d or e   ☐      citizenship or place of organization   united states number of shares beneficially owned by each reporting person with             sole voting power             shared voting power             sole dispositive power           shared dispositive power       aggregate amount beneficially owned by each reporting person        check box if the aggregate amount in row  excludes certain shares see instructions      percent of class represented by amount in row         type of reporting person see instructions   oo    includes  shares of common stock currently held by the other filing persons identified herein and  shares of common stock issuable upon the exercise of warrants held by such filing persons and exercisable within  days of this report  includes shares attributable to the filing person by virtue of its deemed membership in a group as that term is defined for purposes of section d of the securities exchange act the filing person does not admit that it is acting in concert with the other filing persons with respect to the voting or disposition of the securities described herein and attributable to the filing person by virtue of its inclusion in a group pursuant to rule da except as described under item c below  based on  shares of the issuers common stock outstanding upon the completion of the registrants initial public offering based upon the registrants prospectus supplement filed with the commission under rule b on october   schedule d   item  security and issuer this statement relates to shares of common stock of irhythm technologies inc whose principal executive office is located at  townsend street suite  san francisco california    item  identity and background the persons filing this statement and the persons enumerated in response to instruction c of schedule d and the information regarding them are as follows     a kaiser permanente ventures llcseries a a delaware limited liability company kva kaiser permanente ventures  series b a delaware limited liability company kvb the permanente federation  series i llc a delaware limited liability company pfi and the permanente federation  series j llc a delaware limited liability company pfj each a filing person and collectively the filing persons     b the business address of the filing persons is  kaiser plaza suite  oakland california      c present principal occupation or employment of the filing persons and the name principal business and address of any corporation or other organization in which such employment is conducted kva and kvb are investment vehicles used by affiliates of kaiser foundation hospitals kfh a california nonprofit corporation to own securities issued in connection with technology investments by kfh and its affiliates and in this paragraph the term ventures filing persons refers to those two investment vehicles pfi and pfj are investment vehicles used to own securities issued in connection with technology investments by kaiser permanente medical groups and certain of its affiliates and in this paragraph pfi and pfj are referred to collectively as the federation filing persons the ventures filing persons on the one hand and the federation filing persons on the other hand are managed by fully independent committees whose membership does not overlap and which are appointed by separate nonaffiliated entities however from time to time the two management committees meet collectively and confer with respect to the acquisition disposition and voting of securities owned by the several filing persons and certain of their respective affiliates there is no written or unwritten agreement between or among the filing persons relating to such voting power or dispositive power and collective meetings may be discontinued or curtailed at any time accordingly each of the ventures filing persons disclaims that it is acting in concert with respect to the voting and disposition of the securities held by each of the federation filing persons and vice versa except to the extent described above     d during the last five years none of the filing persons has been convicted in a criminal proceeding excluding traffic violations or similar misdemeanors     e during the last five years none of the filing persons was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment decree or final order enjoining future violations of or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws   f usa   item  source and amount of funds or other consideration the common stock now held by the filing persons includesi  shares of common stock purchased by the filing persons collectively at the time of the registrants initial public offering for an aggregate purchase price of  ii shares of common stock issued upon the automatic conversion of convertible preferred stock held by the filing persons immediately prior to consummation of the registrants initial public offering and iii  shares of common stock issuable upon the exercise of warrants held by the filing persons as of the date of this report and exercisable within  days the source of funds for the purchase of all such securities was the corporate personal funds of the several filing persons the filing persons have not purchased any common stock with borrowed funds   item  purpose of transaction the purpose of the filing persons investment in the registrants common stock was to promote and invest in the development of technology owned by the registrant and to achieve financial benefits if any associated with such investments the filing persons do not have any present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs a  j of item  of schedule d except as set forth herein   item  interest in securities of the issuer the beneficial ownership of the common stock by each filer at the date hereof is reflected on that filers cover page except with respect to the purchase of  shares of common stock purchased collectively by kva kvb and pfj in the registrants initial public offering for an aggregate purchase price of  as described in clause i of item  above there were no transactions effected by the filing persons in the common stock within the past sixty  days item  contracts agreements understandings or relationships with respect to securities of the issuer other than the relationships mentioned above to the knowledge of the filing persons none of the filing persons is party to any other contracts arrangements understandings or relationships with respect to any securities of the issuer including but not limited to the transfer or voting of any of the securities finders fees joint ventures loan or option agreements puts or calls guarantees of profits division of profits or loss or the giving or withholding of proxies   item  materials to be filed as exhibits none signature after reasonable inquiry and to the best of my knowledge and belief i certify that the information set forth in this statement is true complete and correct   kaiser permanente ventures llc  series a       date october         s thomas meier       thomas meier svp and corp treasurer kaiser permanente ventures llc  series b       date october         s chris grant       chris grant evp and chief operating officer the permanente federation llc  series i       date october         s claire tamo       claire tamo chief financial officer the permanente federation llc  series j       date october         s claire tamo       claire tamo chief financial officer elevate your investments try it for free kaiser permanente ventures loading team portfolio press about contact partners in health care innovation partners in health care innovation we are dedicated to partnering with entrepreneurs to advance clinical quality service and affordability partners in health care innovation we represent the largest integrated healthcare delivery system in america partners in health care innovation we bring deep clinical operational and healthcare it expertise partners in health care innovation we have over  years of venture capital investing experience with approximately  million under management team investment investment finance  operations sam brasch senior managing director chris grant executive managing director amy belt raimundo managing director liz rockett director shruti kothari director portfolio development and collaboration daniel van den bergh senior associate priyanka mitra associate nemariam mesfin venture fund controller carmen smeester financial analyst gina crisosto executive assistant portfolio information technology information technology services therapeutics diagnostics  drug delivery networked hardware software and medical device discovery reconciliation and management digital evidencebased behavioral health solutions behavioral analytics healthcare data warehouse platform improves the way customers find understand and manage healthrelated information patient encounter platform pharmacy automation using rfid governance risk and compliance software digital behavioral health therapeutics health feedback technology rock health seed fund digital health incubator mhealth data aggregator secure and scalable video collaboration platform exits acquired by api healthcare february  initial public offering february  acquired by covad communications february  improved personalized communications with patients dialysis care for patients with end stage renal disease techenabled private duty care ambulatory cardiac rhythm monitoring epic consulting services applying new methods and equipment to hospital housekeeping exits acquired by towerbrook june  acquired by inverness medical september  acquired by bupa december  acquired by goldman sachs august  acquired by fresenius october  medical device for diagnosis and treatment of pulmonary disorders laparoscopic mechanical implant for acidreflux disease medical device for treatment of morbid obesity respiratory therapy for the treatment of lung and acute breathing disorders exits acquired by cytyc february  acquired by volcano corporation may  acquired by covidien march  acquired by gambro january  emacquired by cryolifeembr  may  medical device for treatment of glaucoma initial public offering april  acquired by mindray june  rapid pointofcare assay for measuring efficacy of antiplatelet medication rapid biomarker based diagnostic tests for hospital based acute conditions celula develops innovative instrument systems for esoteric molecular diagnostics using advanced microfluidics technologies platform combining personalized drug delivery and digital behavior modification support disposable insulin delivery device for type ii diabetes exits initial public offering february  initial public offering may  acquired by becton dickinson february  initial public offering november  press highlights september   chrono therapeutics raises  million in series b financing to advance its clinical platform for personalized drug therapy september   want to quit smoking biotech startup chrono raises m for drugbehavioral combo july   big health raises m to bring evidencebased digital medicine to millions february   alcon expands leadership position in treating glaucoma through acquisition of transcend medical inc february   hometeam receives  million in funding from kaiser permanente ventures january   us renal care and dsi renal finalize merger press room about what we bring dedicated focus on healthcare investing for over fifteen years strategic guidance and support from seasoned healthcare executives experience navigating complex healthcare ecosystem gateway to the nations largest integrated healthcare delivery system and leader in accountable care opportunities for strategic collaboration with the provider that has won the most himss awards for information technology expertise and stage  emr implementation nationally recognized brand name and image access to worldclass limited partner investors including tufts health plan and the hospitals contribution fund of australia approximately m of committed capital kaiser permanente founded in  patient membership  million hospitals  medical offices  employees  physicians  annual revenues  billion presence in  regions across  states largest us single comprehensive electronic medical record system leading evidencebased care delivery model largest nonacademic research organization in the nation research partner with more than  prominent academic institutes kaiser permanentes vision of the future of healthcare contact us kaiser permanente ventures  kaiser plaza nd floor oakland ca  kpventureskporg surface parking is available across from the building or in the kaiser center parking garage at  lakeside drive ×close ×close chris grant executive managing director chris grant is a senior vice president at kaiser permanente and serves as a key member of the executive leadership team mr grant has oversight and management responsibilities for corporate development mergers and acquisitions and care delivery strategy with a focused on expanding kp’s presence and optimizing performance additionally mr grant is the senior leader and executive managing director of kaiser permanentes venture capital group mr grant cofounded the kaiser permanente investment program in  and has overseen multiple funds and more than  investments in leading medical technology companies kaiser permanentes highly successful venture capital function is designed to support the companys healthcare mission while generating venture capital rates of return mr grant brings expertise in digital health it healthcare services devices and diagnostics he currently serves and has served as a board director or advisor to over a dozen medical technology and services companies prior to the formation of the venture fund in  mr grant was responsible for creating and managing a portfolio of new products and business lines for kp before joining kaiser permanente in  mr grant held several positions on the business development and financial management team of rockwell international corp additionally mr grant serves on the board of trustees of a large public school district is an executive advisor to the california healthcare foundation and health and science department of dominican university served on the ca governor’s job creation advisory committee and the board of two charitable foundations mr grant has a bachelor’s degree in business from the university of california santa barbara and has completed comprehensive executive management programs at the harvard business school and kenaan flagler school of business unc at chapel hill as well as the venture capital institute graduate and undergraduate programs portfolio previous ×close sam brasch senior managing director sam brasch joined kaiser permanente ventures as senior managing director he has returned to lead the corporate venture fund’s activities after serving as a venture partner at new leaf venture partners and as a senior advisor to health catalyst sam’s health care industry experience spans more than two decades during his tenure at kaiser permanente ventures from  to  sam led the group’s investments in irhythm technologies health catalyst and nordic consulting and other companies earlier in his career sam was a vice president with frazier healthcare partners a seattlebased venture capital firm and a senior manager with medtronic’s us and european offices sam has also worked in multiple healthcare technology startups he began his career as a management consultant with apmcsc healthcare sam received his bachelor of arts in public policy from stanford university and an mba with a focus on health care management from the wharton school at the university of pennsylvania portfolio previous ×close nemariam mesfin venture fund controller nemariam brings diverse finance and multistage business experience to kaiser permanente ventures as controller he supports the fund’s portfolio company valuation analyses financings liquidation waterfalls internal and external fund reporting for the affiliated venture entities prior to joining kaiser permanente ventures nemariam was a portfolio manager at sunedison a global renewable energy investment company where he managed a portfolio with m in assets prior to joining sunedison he was assistant controller at genstar capital a san francisco based private equity firm that provides solutions and capital for management buyouts publictoprivate transactions and growth capital investments in the healthcare it and financial services industries earlier in his career nemariam worked for prana investments a new york based private equity firm focused on investing in multifamily residential real estate nemariam earned a bsc in accounting from towson university maryland ×close carmen smeester financial analyst carmen is responsible for the venture investment database management and analysis reporting and audit and operational processes she also coordinates the investment closings fund distributions and allocations and acts as a liaison between portfolio companies vc firms auditors legal counsel and executives in addition carmen serves as a board director of vcbc an organization for finance professionals in venture capital dedicated to providing education and community to approximately  members nationwide carmen received her ba in sociology and has completed business administration programs from university of california at berkeley ×close gina crisosto executive assistant gina provides direct administrative support to the kaiser permanente ventures team prior to joining the kp ventures gina spent four years as administrative executive and accountant for a local commercial real estate investment company gina has over  years of customer service experience in various associate and management roles in retail event planning and administrative offices gina is an active and continuing contributor to various charities and organizations including st judes children cancer research association of bridal consultants and the society for the prevention of cruelty to animals spca gina received her bfa in photography and printmaking from the university of the pacific ×close liz rockett director at kp ventures liz focuses on investments in healthcare it digital health and technologyenabled services lizs experience in healthcare it and technologyenabled services is rooted in building and delivering products for the advisory board company outcome now a quintiles company and the trizetto group  prior to joining kp ventures liz ran the health practice at imprint capital advising foundations and endowments on healthcare investments that aligned with their mission interests  liz holds her bachelor’s degree from princeton university as well as an mba and a masters of public health from the university of california berkeley portfolio previous ×close amy belt raimundo managing director amy belt raimundo joined kaiser permanente ventures as managing director amy brings over  years of experience in healthcare investing startup and corporate operations and hospital system consulting immediately prior to joining kaiser amy was the chief business officer of digital health startup evidation health founded by ge ventures and stanford healthcare where she led all commercial and business development activities previously amy spent close to a decade in venture capital focused on healthcare technology as a vice president at covidien ventures and advanced technology ventures atv she led investments in medina medial acquired by medtronic and nevro corporation nyse nvro among others earlier in her career amy held operating roles at guidant corporation acquired by abbott vascular including leading the international launch of the xience drug eluting stent and managing product lines across the us europe and asia she began her career as a management consultant for apmcsc healthcare optimizing operations and clinical guidelines for major hospital systems amy is a kauffman venture fellow as well as founder and president of medtechwomen she holds a ba in economics from yale university and an mba from the university of california at berkeley portfolio ×close shruti kothari director portfolio development and collaboration shruti is responsible for developing and facilitating innovative collaborations between kp stakeholders and portfolio companies prior to joining kp ventures shruti served as the director of partnerships  new market launch for honor she supported the startup’s growth from stealth mode to delivering care in several marketplaces previously shruti was the national lead for kp home health homebased palliative care and hospice care experience strategy and improvement she developed and managed a program that impacted over  million patient visits a year across ncal scal nw and hawaii her quality improvement work yielded significant hhcahps outcome improvement and has been featured in published case studies and national conferences shruti began her career as a health educator health equity advocate and community mobilizer  in this capacity she has worked for the american cancer society stanford health care uc berkeley and kaiser permanente shruti holds a ba in sociology and communications from ucla and a masters of public health from uc berkeley she was a hca corris boyd scholar ×close daniel van den bergh senior associate daniel joins kaiser permanente ventures as a senior associate supporting the team across all aspects of deal due diligence and execution portfolio support and internal operations daniel brings expertise in healthcare startup operations venture capital and investment banking prior to joining us he was director of strategy  operations at lumiata a clinical analytics startup he also previously worked at safeguard scientifics reviewing and executing venture capital investments across the healthcare landscape daniel started his career in healthcare investment banking at citigroup then ec mergers  acquisitions daniel holds an mba in health care management from the wharton school and a bs in biological engineering from cornell university during his free time daniel enjoys road cycling in the santa cruz mountains and marin headlands as well as snowboarding in lake tahoe and when he gets a chance in switzerland where he grew up ×close priyanka mitra associate priyanka joins kaiser permanente ventures as an associate providing leverage to the team across all aspects of deal diligence portfolio analytics  management and transaction execution priyanka is a graduate of harvard college where she pursued premedical studies and was named a harvard college scholar given a lifelong interest in issues pertaining to global healthcare systems economics  policy she completed healthcare economicspolicyfocused harvard research fellowships in chile and spain while in college she has completed scientific research fellowships at harvard medical school in neurobiological sciences as well as at mt sinai of new york university in cardiovascular medicine prior to joining the team at kp ventures she worked at bridgewater associates a connecticutbased global macroeconomic hedge fund in research she is passionate about empowering the next generation of worldchanging healthcare tech entrepreneurs through private equity  venture capital investing   priyanka is committed to serving healthcarefocused causes as a marathon runner and ironman triathlete she has raised thousands of dollars to go to causes that support scientific and medical research she is dedicated to the fight to end hivaids worldwide and to this end has been active for over a decade in fundraising and leading initiatives for this cause in the us as well as abroad in africa india and other third world countries in her free time she is active in the harvard alumni community and enjoys spending time with friends  family traveling globally reading and outdoor sports like hiking and trailrunning   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft kaiser permanente ventures llc series a d filing  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member home  insider trading  latest d and g filings  d filing  filing details accession number  form type d filing publication date   filed by kaiser permanente ventures llc series a company irhythm technologies inc filing date  sec url d filing ownership summary please notice the below summary table is generated without human intervention and may contain errors please refer to the complete filing displayed below for exact figures name sole voting power shared voting power sole dispositive power shared dispositive power aggregate amount owned power percent of class kaiser permanente ventures       kaiser permanente ventures       the permanente federation       the permanente federation       filing     united states securities and exchange commission washington dc      schedule da under the securities exchange act of  amendment no      irhythm technologies inc name of issuer common stock title of class of securities   cusip number marcus j williams davis wright tremaine llp  third avenue suite  seattle wa    name address and telephone number of person authorized to receive notices and communications june   date of event which requires filing of this statement     if the filing person has previously filed a statement on schedule g to report the acquisition that is the subject of this schedule d and is filing this schedule because of §§ de df or dg check the following box  ☐     note schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits see § d for other parties to whom copies are to be sent      the remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page the information required on the remainder of this cover page shall not be deemed to be filed for the purpose of section  of the securities exchange act of  act or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act however see the notes       cusip no           names of reporting persons   kaiser permanente ventures llc series a     check the appropriate box if a member of a group see instructions a  ☐        b  ☒       sec use only       source of funds see instructions   pf     check if disclosure of legal proceedings is required pursuant to items d or e   ☐     citizenship or place of organization   united states number of shares beneficially owned by each reporting person with             sole voting power            shared voting power            sole dispositive power          shared dispositive power      aggregate amount beneficially owned by each reporting person       check box if the aggregate amount in row  excludes certain shares see instructions     percent of class represented by amount in row       type of reporting person see instructions   oo   includes  shares of common stock of irhythm technologies inc the issuer currently held by the filing person identified above and  shares of common stock issuable upon the exercise of warrants held by such filing person and exercisable within  days of this report  includes shares attributable to the filing person by virtue of its deemed membership in a group as that term is defined for purposes of section d of the securities exchange act of  as amended the exchange act the filing person is an affiliate of each of the other filing persons identified herein the filing person does not admit that it is acting in concert with the other filing persons with respect to the voting or disposition of the securities described herein and attributable to the filing person by virtue of its inclusion in a group pursuant to rule da    based on  shares of the issuers common stock outstanding as of april   as reported in the issuers form q filed with the securities and exchange commission the sec on may   cusip no           names of reporting persons   kaiser permanente ventures llc series b     check the appropriate box if a member of a group see instructions a  ☐        b  ☒       sec use only       source of funds see instructions   pf     check if disclosure of legal proceedings is required pursuant to items d or e   ☐     citizenship or place of organization   united states number of shares beneficially owned by each reporting person with             sole voting power            shared voting power            sole dispositive power          shared dispositive power      aggregate amount beneficially owned by each reporting person       check box if the aggregate amount in row  excludes certain shares see instructions     percent of class represented by amount in row       type of reporting person see instructions   oo   includes  shares of common stock currently held by the filing person identified above and  shares of common stock issuable upon the exercise of warrants held by such filing person and exercisable within  days of this report    includes shares attributable to the filing person by virtue of its deemed membership in a group as that term is defined for purposes of section d of the exchange act   the filing person is an affiliate of each of the other filing persons identified herein the filing person does not admit that it is acting in concert with the other filing persons with respect to the voting or disposition of the securities described herein and attributable to the filing person by virtue of its inclusion in a group pursuant to rule da    based on  shares of the issuers common stock outstanding as of april   as reported in the issuers form q filed with the sec on may   cusip no           names of reporting persons   the permanente federation llc series i     check the appropriate box if a member of a group see instructions a  ☐        b  ☒       sec use only       source of funds see instructions   pf     check if disclosure of legal proceedings is required pursuant to items d or e   ☐     citizenship or place of organization   united states number of shares beneficially owned by each reporting person with             sole voting power            shared voting power            sole dispositive power          shared dispositive power      aggregate amount beneficially owned by each reporting person      check box if the aggregate amount in row  excludes certain shares see instructions     percent of class represented by amount in row       type of reporting person see instructions   oo   includes shares attributable to the filing person by virtue of its deemed membership in a group as that term is defined for purposes of section d of the exchange act the filing person is an affiliate of each of the other filing persons identified herein the filing person does not admit that it is acting in concert with the other filing persons with respect to the voting or disposition of the securities described herein and attributable to the filing person by virtue of its inclusion in a group pursuant to rule da    based on  shares of the issuers common stock outstanding as of april   as reported in the issuers form q filed with the sec on may   cusip no           names of reporting persons   the permanente federation llc series j     check the appropriate box if a member of a group see instructions a  ☐        b  ☒       sec use only       source of funds see instructions   pf     check if disclosure of legal proceedings is required pursuant to items d or e   ☐     citizenship or place of organization   united states number of shares beneficially owned by each reporting person with             sole voting power            shared voting power            sole dispositive power          shared dispositive power      aggregate amount beneficially owned by each reporting person       check box if the aggregate amount in row  excludes certain shares see instructions     percent of class represented by amount in row       type of reporting person see instructions   oo   includes  shares of common stock currently held by the filing person identified above and  shares of common stock issuable upon the exercise of warrants held by such filing person and exercisable within  days of this report  includes shares attributable to the filing person by virtue of its deemed membership in a group as that term is defined for purposes of section d of the exchange act the filing person is an affiliate of each of the other filing persons identified herein the filing person does not admit that it is acting in concert with the other filing persons with respect to the voting or disposition of the securities described herein and attributable to the filing person by virtue of its inclusion in a group pursuant to rule da    based on  shares of the issuers common stock outstanding as of april   as reported in the issuers form q filed with the sec on may   schedule d explanatory note this statement on schedule d originally filed with the securities and exchange commission the sec on november   the schedule d by kaiser permanente ventures llc series a kaiser permanente ventures llc series b the permanente federation llc series i and the permanente federation llc series j each a filing person and collectively the filing persons is hereby amended by this amendment no  to the schedule d this amendment this amendment relates to the sale of shares of common stock the common stock of irhythm technologies inc the issuer by the filing persons through june  capitalized terms used herein and not otherwise defined have the meanings assigned to such terms in the schedule d except as set forth in this amendment the schedule d remains unchanged this amendment is the filing persons final amendment to the schedule d and is an exit filing by virtue of the filing persons aggregate beneficial ownership of less than  of the registrants common stock   item  interest in securities of the issuer paragraphs a  c and e of item  of the schedule d are hereby amended and restated in their entirety as follows ab the responses of the filing persons to rows  through  of the cover pages of this amendment are incorporated herein by reference as of the date hereof the filing persons beneficially own an aggregate of  shares of common stock including  shares of common stock issuable upon the exercise of warrants held by such filing persons and exercisable within  days of this report which represent approximately  of the outstanding common stock all percentages set forth herein are based on  shares of common stock outstanding as of april   as reported in the issuers form q filed with the sec on may     c the filing persons effected the following transactions in the common stock in open market transactions on the dates indicated below and such transactions are the only transactions in the common stock by the filing persons since  days before the date of this amendment      sale of common stock by kaiser permanente ventures llc series a in the past  days   date of sale    number ofshares sold    price pershare         price range    april                    april                    april                    april                    april                                       april                    may                    may                    may                    may                    may                    may                    may                    june                    june                        sale of common stock by kaiser permanente ventures llc series b in the past  days   date of sale    number ofshares sold    price pershare         price range    april                    april                    april                    april                    april                    april                    may                    may                    may                    may                    may                    may                    may                    june                    june                        sale of common stock by the permanente federation llc series i in the past  days   date of sale    number ofshares sold    price pershare         price range    april                    april                    april                    april                    april                    april                    may                    may                    may                    may                                       may                    may                    may                    june                    june                        sale of common stock by the permanente federation llc series j in the past  days   date of sale    number ofshares sold    price pershare         price range    april                    april                    april                    april                    april                    april                    may                    may                    may                    may                    may                    may                    may                    june                    june                      the shares of common stock disclosed above were sold in multiple transactions at prices within the price ranges specified for each date above the price reported in each price per share column is the weighted average price of the shares of common stock sold by the respective filing person on each date each filing person will undertake to provide to the staff of the sec upon request full information regarding the number of shares of common stock sold at each separate price   e on april   the filing persons sold an aggregate of  shares of common stock and consequently no longer beneficially owned  or more of the total outstanding shares of common stock as of such date signature after reasonable inquiry and to the best of my knowledge and belief i certify that the information set forth in this statement is true complete and correct   kaiser permanente ventures llc series a     date july       s thomas meier     thomas meier svp and corp treasurer kaiser permanente ventures llc series b     date july       s chris grant     chris grant evp and chief operating officer the permanente federation llc series i     date july       s claire tamo     claire tamo chief financial officer the permanente federation llc series j     date july       s claire tamo     claire tamo chief financial officer  hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds hot topics apple aapl latest stock news  company profile warren buffett news  analysis  portfolio  stock picks biggest insider purchases  sales news  analysis  data screener google goog latest stock news  company profile microsoft msft latest stock news  company profile home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved liz rockett  director at kaiser permanente ventures news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink liz rockett director at kaiser permanente ventures overview in the news relationships paths education memberships career history boards  committees nonprofit donations  grants liz rockett director at kaiser permanente ventures overview board seats  number of relationships this person is connected to  people in the news see more pr newswire september   chrono therapeutics raises  million in series b financing to advance its clinical platform for personalized drug therapy marketwired july   big health raises m to bring evidencebased digital medicine to millions relationships see details guy dipierro founder at chrono therapeutics inc alan j levy chairman  chief executive officer at chrono therapeutics inc william rindfuss executive director strategic programs at university of california berkeley  haas school of business aidan king managing partner  cofounder at fountain healthcare partners ltd steven james executive chairman  chief executive officer at pionyr immunotherapeutics inc james w young venture partner at am venture management llc wende hutton general partner seasoned strategist at canaan management inc tim kilgallon cofounder at bohola llc chris m grant member of the senior executive management team at kaiser foundation health plan inc sam brasch senior managing director at kaiser permanente ventures see  more listings with relsci professional start my free trial ➤ see  more paths to liz rockett liz rockett you connections via relationship science liz rockett sync your contacts to see how you can connect with liz rockett start my free trial ➤ see more educational background mph  class of   university of california berkeley  school of public health mba  class of   university of california berkeley  haas school of business the walter a haas school of business also known as the haas school of business or simply haas is one of  schools and colleges at the university of california berkeley the school runs a range of programs and is consistently ranked among the best in the country known for its small class size academic rigor and application selectivity haas is one of the most prestigious business schools in the world it is the second oldest business school in the united states ab  princeton university princeton university is a vibrant community of scholarship and learning that stands in the nations service and in the service of all nations chartered in  princeton is the fourtholdest college in the united states princeton is an independent coeducational nondenominational institution that provides undergraduate and graduate instruction in the humanities social sciences natural sciences and engineering as a worldrenowned research university princeton seeks to achieve the highest levels of distinction in the discovery and transmission of knowledge and understanding at the same time princeton is distinctive among research universities in its commitment to undergraduate teaching today more than  faculty members instruct approximately  undergraduate students and  graduate students the universitys generous financial aid program ensures that talented students from all economic backgrounds can afford a princeton education memberships mentor current startup weekend llc startup weekend is a hour weekend event during which groups of developers business managers startup enthusiasts marketing gurus graphic artists and more pitch ideas for new startup companies form teams around those ideas and work to develop a working prototype demo or presentation by sunday evening startup weekend has grown into an organization with a global presence as of july  startup weekend has reached  countries involving over  entrepreneurs startup weekend is run by techstars mentor current springboard enterprises inc springboard is a highlyvetted expert network of innovators investors and influencers who are dedicated to building highgrowth technologyoriented companies led by women its a nonprofit c organization based locally in the usa but acting globally to accelerate women entrepreneurs’ access to growth capital career history director current kaiser permanente ventures kaiser permanente ventures focuses on investments in emerging medical technologies including medical devices healthcare services and healthcare information technology companies the firm seeks to generate attractive rates of return through investments in innovative companies with products or services that improve healthcare quality service and affordability for kaiser permanente members companies should have us annual market potential greater than  million and an experienced management team kaiser permanente ventures provides financing for series a or later rounds and works with a syndicate of leading venture capital healthcare investors to take equity positions of  million to  million director health practice prior imprint capital advisors llc imprint capital advisors llc a subsidiary of the goldman sachs group inc is an american company located in san francisco ca the firm provides investment advice goldman sachs asset management lp acquired imprint capital advisors llc  interim director prior health  llc health  promotes showcases and catalyzes new technologies in health care we do this through a worldwide series of conferences codeathons prize challenges and more we also have the leading market intelligence on new health technology companies professional prior the advisory board company the advisory board company is a global research technology and consulting firm partnering with  leaders in  organizations across health care and higher education through our innovative membership model we collaborate with executives and their teams to elevate performance and solve their most pressing challenges we provide strategic guidance actionable insights webbased software solutions and comprehensive implementation and management services we are guided by the spirit of generosity serving our members beyond expectation and with honest appreciation in every encounte professional prior the permanente medical group inc the permanente medical group inc provides medical services it operates as a multispecialty group medical practice offering health care service to the california region the firm also provides and arranges for medical care for kaiser foundation health plan members in each respective region the company was founded in  and is headquartered in arcadia ca professional prior outcome sciences llc founded in  outcome sciences inc dba outcome spun out of a harvard affiliated research laboratory the company has focused on outcomes studies since its inception and has dedicated itself to leading the way in registries postapproval research and quality improvement initiativesthe firms world headquarters are located in cambridge ma and stprex switzerland and it has regional offices in chicago washington dc london mumbai tokyo and sydneythe firm has designed developed and managed an industryleading number of patient registries and postapproval studies and have expertise and experience in more than  therapeutic areas its programs include thousands of sites and millions of patients across the globe outcome has program participants in more than  countries on  continents with more than  us hospitals participating in at least one outcome registryin addition to working with life sciences companies it also partner with many providers and healthcare organizations specialty associations hospital associations pharmacist associations managed care organizations state departments of public health quality improvement organizations qios and government agencies in fact nearly  healthcare organizations are its direct customersoutcome regularly works with thought leaders regulators and government agencies from many regions of the world including the european medicines agency the agency for healthcare research and quality the us food and drug administration the uk national institute for health and clinical excellence and many more innovation group for payer provider  patient incentive alignment prior trizetto corporation trizetto corp provides information technology solutions for healthcare industry it offers patient access claims management denials management contract management contract management and patient financial the company was founded by jeffrey h margolis on april   and is headquartered in englewood co boards  committees corporate boards ▾ member board of directors   current chrono therapeutics inc chrono therapeutics inc produces transdermal drug products it is a pharmaceutical company with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery that offers realtime behavioral support the company was founded by guy dipierro in  and is headquartered in hayward ca nonprofit boards ▾ member alumni council current university of california berkeley  haas school of business the walter a haas school of business also known as the haas school of business or simply haas is one of  schools and colleges at the university of california berkeley the school runs a range of programs and is consistently ranked among the best in the country known for its small class size academic rigor and application selectivity haas is one of the most prestigious business schools in the world it is the second oldest business school in the united states nonprofit donations  grants     aids action committee of massachusetts inc stop the aids epidemic and related health inequalities by eliminating new infections maximizing healthier outcomes of those infected and at risk and attacking the root cause of hivaids other affiliations liz rockett is affiliated with kaiser permanente ventures imprint capital advisors llc health  llc the advisory board company the permanente medical group inc outcome sciences llc trizetto corporation chrono therapeutics inc university of california berkeley  haas school of business youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ kaiser permanente ventures llc series a top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active kaiser permanente ventures llc series a • oakland ca how do i update this listing kaiser permanente ventures llc series a is based out of oakland whalewisdom has at least  dg filings in our database for kaiser permanente ventures llc series a summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from kaiser permanente ventures llc series a enter your email address below and choose submit your email cancel contact info kaiser permanente ventures llc series a one kaiser plaza suite  oakland ca     business phone   recent sec filings sc da filed on  sc d filed on  current dg holdings stock sector shares held market value rank source source date unknown unknown    d  irhythm technologies inc irtc health care    d  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft